Critical Decision Points in Insomnia

Differences in Mechanisms of Action Among Insomnia Drug Classes

Non-GABA Receptor Targeted Agents

Switching to Non-GABA Receptor Targeted Therapy

Consideration of Sleep and Medical History

Dosing and Titrating Treatment

Transitioning From a BZD or Non-BZD to a Non-GABA Receptor Targeted Agent

Managing Patient Expectations

Key Educational Points When Starting Non-GABA Receptor Targeted Agents

Following Up and Addressing Other Issues Patients May Have During the Transition

Concluding Remarks

Abbreviations